Annamycin consistently demonstrates no evidence of cardiotoxicity across five clinical trials - This next-generation anthracycline demonstrates safety and promising early activity in treating multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback